# PUVA Maintenance Therapy in Mycosis Fungoides

Source: https://onco.cc/trials/nct01686594/  
OnCo record `nct01686594` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Methoxsalen in Cutaneous T-cell lymphoma and Peripheral T-cell lymphomas, run by Medical University of Graz, completed.

## Summary

PUVA Maintenance Therapy in Mycosis Fungoides is a phase 3 interventional study registered as NCT01686594 by Medical University of Graz, with 28 participants recorded, started 2013-02 and reaching its primary completion in 2018-07-02. Interventions recorded: 8-methoxypsoralen. Conditions recorded: Patch/Plaque Stage Mycosis Fungoides.

Linked to the drug Methoxsalen because the registry names it among its interventions and Cutaneous T-cell lymphoma and Peripheral T-cell lymphomas among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01686594
- Phase: 3
- Setting: A Multi-center, Randomized Study on Oral 8-methoxypsoralen Plus UVA With or Without Maintenance Therapy in Mycosis Fungoides EORTC/ISCL Stage IA to IIB
- Sponsor: Medical University of Graz
- Enrolled: 28

## Sources

- ClinicalTrials.gov NCT01686594: https://clinicaltrials.gov/study/NCT01686594

## Connected records

- cancers: [Cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)](https://onco.cc/cancers/cutaneous-t-cell-lymphoma/), [Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma)](https://onco.cc/cancers/peripheral-t-cell-lymphoma/)
- drugs: [Methoxsalen (extracorporeal photopheresis)](https://onco.cc/drugs/methoxsalen-ecp/)

---
JSON: https://onco.cc/api/v1/entities/nct01686594.json